Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • BioTech • Hardware (& Manufacturing) • Retail (& E-Commerce) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Investment Management |
Stages | Expansion, MBO/LBO |
Investing | United States • Canada • Russia |
Fung Capital USA is a venture capital fund that operates as the investment arm of the prestigious Fung family in Hong Kong, renowned for their influence in global consumer products distribution and retailing through the Fung Group. This group comprises notable entities such as Li & Fung, Global Brands Group, and Fung Retailing. The collective prowess of the group is reflected in their impressive US$22 billion revenues and a robust workforce of 45,000 employees spread across more than 40 countries. With their headquarters at 1050 Waltham Street, Suite 300, Lexington, Massachusetts, Fung Capital USA specializes in equity investments, particularly focusing on expansion opportunities as well as management buyouts and leveraged buyout scenarios. The fund is deeply interested in propelling companies that stand at the intersection of a variety of industries, such as B2B software services that span web marketplaces, SaaS platforms, biotech, hardware and manufacturing, retail and e-commerce, IoT and wearables, AI and big data, health tech and fitness, medical devices, and hospital services, in addition to investment management. Their investment thesis is centered on identifying and nurturing B2B technology companies that are pivotal to enabling omni-channel retailing and enhancing supply chain efficiency, which is in line with the extensive global supply chain and retailing expertise of the Fung Group.